Anti-Monopoly Guidelines for the Active Pharmaceutical Ingredient Sector

关于原料药领域的反垄断指南

Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector

By Susan Mok

(国务院反垄断委员会于二零二一年十一月十五日发布施行。)

(Issued by the Anti-monopoly Commission of the State Council on, and effective as of, November 15, 2021.)

国反垄发〔2021〕3号

第一章 总 则

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

  • ✓ A database of 3000+ essential documents, including key PRC laws translated into English
  • ✓ Newsletters with business-critical and sector-specific updates
  • ✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)